Cholesterol Crystals Associate With Coronary Plaque Vulnerability In Vivo

Cholesterol crystals on FD-OCT are not histopathologically validated. Because of the relatively small study population, a larger study is required to elucidate the effect of cholesterol crystals on clinical outcome. In summary, cholesterol crystals within target vessels requiring percutaneous corona...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 65; no. 6; pp. 630 - 632
Main Authors Kataoka, Yu, MD, Puri, Rishi, MBBS, PhD, Hammadah, Muhammad, MD, Duggal, Bhanu, MD, Uno, Kiyoko, MD, PhD, Kapadia, Samir R., MD, Tuzcu, E. Murat, MD, Nissen, Steven E., MD, Nicholls, Stephen J., MBBS, PhD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 17.02.2015
Elsevier Limited
Subjects
Apoptosis
Cardiology
Cardiovascular
Cardiovascular disease
Cholesterol
Cholesterol - metabolism
Coronary Artery Disease - diagnosis
Coronary Artery Disease - metabolism
Coronary vessels
Coronary Vessels - metabolism
Diagnostic Imaging - methods
Humans
Internal Medicine
Lipids
Plaque, Atherosclerotic - diagnosis
Plaque, Atherosclerotic - metabolism
Online AccessGet full text

Cover

More Information
Summary:Cholesterol crystals on FD-OCT are not histopathologically validated. Because of the relatively small study population, a larger study is required to elucidate the effect of cholesterol crystals on clinical outcome. In summary, cholesterol crystals within target vessels requiring percutaneous coronary intervention were observed in 39.6% of patients with stable coronary artery disease.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2014.11.039